Hypoglycemia and diabetes

A report of aworkgroup of the American diabetes association and the endocrine society

Elizabeth R. Seaquist, John Anderson, Belinda Childs, Philip Cryer, Samuel Dagogo-Jack, Lisa Fish, Simon R. Heller, Henry Rodriguez, James Rosenzweig, Robert Vigersky

Research output: Contribution to journalReview article

611 Citations (Scopus)

Abstract

OBJECTIVE-To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diabetes Association and The Endocrine Society and to provide guidance about how this new information should be incorporated into clinical practice. PARTICIPANTS-Five members of the American Diabetes Association and five members of The Endocrine Societywith expertise in different aspects of hypoglycemia were invited by the Chair, who is a member of both, to participate in a planning conference call and a 2-day meeting that was also attended by staff from both organizations. Subsequent communications took place via e-mail and phone calls. The writing group consisted of those invitees who participated in the writing of the manuscript. The workgroupmeeting was supported by educational grants to theAmerican Diabetes Association from Lilly USA, LLC and Novo Nordisk and sponsorship to the American Diabetes Association fromSanofi. The sponsors had no input into the development of or content of the report. EVIDENCE-The writing group considered data fromrecent clinical trials and other studies to update the prior workgroup report. Unpublished data were not used. Expert opinion was used to develop some conclusions. CONSENSUS PROCESS-Consensus was achieved by group discussion during conference calls and face-to-facemeetings, as well as by iterative revisions of the written document. The document was reviewed and approved by the American Diabetes Association's Professional Practice Committee in October 2012 and approved by the Executive Committee of the Board of Directors in November 2012 and was reviewed and approved by The Endocrine Society's Clinical Affairs Core Committee in October 2012 and by Council in November 2012. CONCLUSIONS-The workgroup reconfirmed the previous definitions of hypoglycemia in diabetes, reviewed the implications of hypoglycemia on both short- and long-term outcomes, considered the implications of hypoglycemia on treatment outcomes, presented strategies to prevent hypoglycemia, and identified knowledge gaps that should be addressed by future research. In addition, tools for patients to report hypoglycemia at each visit and for clinicians to document counseling are provided.

Original languageEnglish (US)
Pages (from-to)1384-1395
Number of pages12
JournalDiabetes care
Volume36
Issue number5
DOIs
StatePublished - May 1 2013

Fingerprint

Hypoglycemia
Training Support
Professional Practice
Manuscripts
Expert Testimony
Postal Service
Counseling
Consensus
Communication
Clinical Trials
Organizations

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Hypoglycemia and diabetes : A report of aworkgroup of the American diabetes association and the endocrine society. / Seaquist, Elizabeth R.; Anderson, John; Childs, Belinda; Cryer, Philip; Dagogo-Jack, Samuel; Fish, Lisa; Heller, Simon R.; Rodriguez, Henry; Rosenzweig, James; Vigersky, Robert.

In: Diabetes care, Vol. 36, No. 5, 01.05.2013, p. 1384-1395.

Research output: Contribution to journalReview article

Seaquist, ER, Anderson, J, Childs, B, Cryer, P, Dagogo-Jack, S, Fish, L, Heller, SR, Rodriguez, H, Rosenzweig, J & Vigersky, R 2013, 'Hypoglycemia and diabetes: A report of aworkgroup of the American diabetes association and the endocrine society', Diabetes care, vol. 36, no. 5, pp. 1384-1395. https://doi.org/10.2337/dc12-2480
Seaquist, Elizabeth R. ; Anderson, John ; Childs, Belinda ; Cryer, Philip ; Dagogo-Jack, Samuel ; Fish, Lisa ; Heller, Simon R. ; Rodriguez, Henry ; Rosenzweig, James ; Vigersky, Robert. / Hypoglycemia and diabetes : A report of aworkgroup of the American diabetes association and the endocrine society. In: Diabetes care. 2013 ; Vol. 36, No. 5. pp. 1384-1395.
@article{07271e4d6a5945d7afb777ee079802a4,
title = "Hypoglycemia and diabetes: A report of aworkgroup of the American diabetes association and the endocrine society",
abstract = "OBJECTIVE-To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diabetes Association and The Endocrine Society and to provide guidance about how this new information should be incorporated into clinical practice. PARTICIPANTS-Five members of the American Diabetes Association and five members of The Endocrine Societywith expertise in different aspects of hypoglycemia were invited by the Chair, who is a member of both, to participate in a planning conference call and a 2-day meeting that was also attended by staff from both organizations. Subsequent communications took place via e-mail and phone calls. The writing group consisted of those invitees who participated in the writing of the manuscript. The workgroupmeeting was supported by educational grants to theAmerican Diabetes Association from Lilly USA, LLC and Novo Nordisk and sponsorship to the American Diabetes Association fromSanofi. The sponsors had no input into the development of or content of the report. EVIDENCE-The writing group considered data fromrecent clinical trials and other studies to update the prior workgroup report. Unpublished data were not used. Expert opinion was used to develop some conclusions. CONSENSUS PROCESS-Consensus was achieved by group discussion during conference calls and face-to-facemeetings, as well as by iterative revisions of the written document. The document was reviewed and approved by the American Diabetes Association's Professional Practice Committee in October 2012 and approved by the Executive Committee of the Board of Directors in November 2012 and was reviewed and approved by The Endocrine Society's Clinical Affairs Core Committee in October 2012 and by Council in November 2012. CONCLUSIONS-The workgroup reconfirmed the previous definitions of hypoglycemia in diabetes, reviewed the implications of hypoglycemia on both short- and long-term outcomes, considered the implications of hypoglycemia on treatment outcomes, presented strategies to prevent hypoglycemia, and identified knowledge gaps that should be addressed by future research. In addition, tools for patients to report hypoglycemia at each visit and for clinicians to document counseling are provided.",
author = "Seaquist, {Elizabeth R.} and John Anderson and Belinda Childs and Philip Cryer and Samuel Dagogo-Jack and Lisa Fish and Heller, {Simon R.} and Henry Rodriguez and James Rosenzweig and Robert Vigersky",
year = "2013",
month = "5",
day = "1",
doi = "10.2337/dc12-2480",
language = "English (US)",
volume = "36",
pages = "1384--1395",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "5",

}

TY - JOUR

T1 - Hypoglycemia and diabetes

T2 - A report of aworkgroup of the American diabetes association and the endocrine society

AU - Seaquist, Elizabeth R.

AU - Anderson, John

AU - Childs, Belinda

AU - Cryer, Philip

AU - Dagogo-Jack, Samuel

AU - Fish, Lisa

AU - Heller, Simon R.

AU - Rodriguez, Henry

AU - Rosenzweig, James

AU - Vigersky, Robert

PY - 2013/5/1

Y1 - 2013/5/1

N2 - OBJECTIVE-To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diabetes Association and The Endocrine Society and to provide guidance about how this new information should be incorporated into clinical practice. PARTICIPANTS-Five members of the American Diabetes Association and five members of The Endocrine Societywith expertise in different aspects of hypoglycemia were invited by the Chair, who is a member of both, to participate in a planning conference call and a 2-day meeting that was also attended by staff from both organizations. Subsequent communications took place via e-mail and phone calls. The writing group consisted of those invitees who participated in the writing of the manuscript. The workgroupmeeting was supported by educational grants to theAmerican Diabetes Association from Lilly USA, LLC and Novo Nordisk and sponsorship to the American Diabetes Association fromSanofi. The sponsors had no input into the development of or content of the report. EVIDENCE-The writing group considered data fromrecent clinical trials and other studies to update the prior workgroup report. Unpublished data were not used. Expert opinion was used to develop some conclusions. CONSENSUS PROCESS-Consensus was achieved by group discussion during conference calls and face-to-facemeetings, as well as by iterative revisions of the written document. The document was reviewed and approved by the American Diabetes Association's Professional Practice Committee in October 2012 and approved by the Executive Committee of the Board of Directors in November 2012 and was reviewed and approved by The Endocrine Society's Clinical Affairs Core Committee in October 2012 and by Council in November 2012. CONCLUSIONS-The workgroup reconfirmed the previous definitions of hypoglycemia in diabetes, reviewed the implications of hypoglycemia on both short- and long-term outcomes, considered the implications of hypoglycemia on treatment outcomes, presented strategies to prevent hypoglycemia, and identified knowledge gaps that should be addressed by future research. In addition, tools for patients to report hypoglycemia at each visit and for clinicians to document counseling are provided.

AB - OBJECTIVE-To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diabetes Association and The Endocrine Society and to provide guidance about how this new information should be incorporated into clinical practice. PARTICIPANTS-Five members of the American Diabetes Association and five members of The Endocrine Societywith expertise in different aspects of hypoglycemia were invited by the Chair, who is a member of both, to participate in a planning conference call and a 2-day meeting that was also attended by staff from both organizations. Subsequent communications took place via e-mail and phone calls. The writing group consisted of those invitees who participated in the writing of the manuscript. The workgroupmeeting was supported by educational grants to theAmerican Diabetes Association from Lilly USA, LLC and Novo Nordisk and sponsorship to the American Diabetes Association fromSanofi. The sponsors had no input into the development of or content of the report. EVIDENCE-The writing group considered data fromrecent clinical trials and other studies to update the prior workgroup report. Unpublished data were not used. Expert opinion was used to develop some conclusions. CONSENSUS PROCESS-Consensus was achieved by group discussion during conference calls and face-to-facemeetings, as well as by iterative revisions of the written document. The document was reviewed and approved by the American Diabetes Association's Professional Practice Committee in October 2012 and approved by the Executive Committee of the Board of Directors in November 2012 and was reviewed and approved by The Endocrine Society's Clinical Affairs Core Committee in October 2012 and by Council in November 2012. CONCLUSIONS-The workgroup reconfirmed the previous definitions of hypoglycemia in diabetes, reviewed the implications of hypoglycemia on both short- and long-term outcomes, considered the implications of hypoglycemia on treatment outcomes, presented strategies to prevent hypoglycemia, and identified knowledge gaps that should be addressed by future research. In addition, tools for patients to report hypoglycemia at each visit and for clinicians to document counseling are provided.

UR - http://www.scopus.com/inward/record.url?scp=84876796916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876796916&partnerID=8YFLogxK

U2 - 10.2337/dc12-2480

DO - 10.2337/dc12-2480

M3 - Review article

VL - 36

SP - 1384

EP - 1395

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 5

ER -